Pharmaceutical Polymers and Excipients: A Definitive Study Guide

FUNDAMENTALS OF POLYMER SCIENCE AND SYNTHESIS

Polymers are substances characterized by very large molecular weights, composed of repeating units known as monomers that are linked throughout their chains. Their classification is primarily based on their synthetic origin, with two major classes being condensation polymers and chain (addition) polymers. In condensation polymerization, monomers possessing two functional groups react with one another to establish covalent bonds. A typical example involves monomers with $OH$ groups reacting with monomers containing $-COOH$ groups, which produces a polymer featuring an ester linkage. As this polymerization process continues, the number of repeating units, denoted as $n$, increases over time. The molecular weight of the resulting polymer is directly proportional to its degree of polymerization. In specific cases where monomers with bifunctional groups $AA$ and $BB$ are used in exact proportions, the resulting molecules can achieve infinite molecular weight, structured as $-AA-BB-AA-BB-AA-BB-AA-BB$.

Chain polymerization follows a different pathway, where monomers with unsaturated bonds polymerize in the presence of an initiator. This initiator creates an active site at the terminal end of the chain. In the context of pharmaceutical applications, most polymers are synthesized via a process of free radical polymerization. When more than two types of monomers are involved in the process, it is termed copolymerization. The specific properties of copolymers are determined by the monomer type and their sequence. Random copolymers feature repeating units arranged haphazardly. Alternating copolymers have two repeating units arranged in an orderly, alternating fashion. Block copolymers consist of long sequences of each repeating unit along the main chain. Grafted copolymers involve long sequences of one repeating unit being attached as branches to the backbone of a different polymer.

CLASSIFICATION AND UTILITY IN DRUG DELIVERY SYSTEMS

Polymers are further classified by their synthesis method, mechanical behavior, processing characteristics, and morphology. In medical and pharmaceutical fields, they are categorized by origin into natural, semisynthetic, and synthetic types. Natural polymers include gelatin, alginic acid, xanthan gum, arabic gum, and chitosan. Semisynthetic derivatives often include cellulose variants such as methyl cellulose, ethyl cellulose, hydroxyethyl cellulose, and various cellulose acetates. Synthetic polymers used in pharmacy include polyacrylic acid (Carbopol), poly(vinyl alcohol), poly(lactic acid), and poly(anhydrides).

In drug delivery, polymers are utilized to provide sustained release by encapsulating drugs within their therapeutic windows. This approach minimizes the peaks and valleys of drug concentration typically seen in immediate-release forms. For oral controlled release (CR) applications, common choices include natural polymers (cellulose), their derivatives (methyl cellulose), and nondegradable synthetic polymers like poly(vinyl pyrrolidone) and polymethacrylates. Because these polymers are often well-established in terms of regulatory status, innovation in oral CR systems focuses on combining different polymers and perfecting solid dosage form fabrication rather than designing entirely new polymers.

For injectable or implantable CR systems, the requirements are more stringent. The polymer must provide controlled release while being biocompatible and nontoxic. Often, these applications require biodegradability, meaning the polymer must break down into safe by-products that the body can clear. Thus, polymers serve as essential excipients for both oral and parenteral controlled release formulations. Examples of natural polymers and their functions include Gelatin (binder), Xanthan gum (matrix), and Chitosan (membrane). Synthetic examples include Poly(lactic acid) and Poly(glycolic acid), which are primarily used for their biodegradable properties.

REQUIREMENTS FOR PHARMACEUTICAL POLYMER SELECTION

An ideal polymer for pharmaceutical applications must meet several criteria. First, it must be biocompatible and degradable, breaking down in vivo into fragments that are easily excreted. Second, the degradation products must be nontoxic and must not trigger inflammatory responses. Third, the degradation must occur within a timeframe suited to the specific application, ranging from several days to several months. Finally, the polymer must offer versatile mechanical properties. For example, polymers used in stent coatings must be elastomeric, while those used in microsphere processing need a high glass transition temperature ($Tg$). Because no single polymer satisfies all these requirements, companies develop application-specific polymers or series of polymers with variable structures. Novel polymers without a history of biological use are subject to intense regulatory scrutiny and require extensive biological and physicochemical testing to prove safety.

BIOERODIBLE AND BIODEGRADABLE POLYMER CLASSES

The poly($\alpha$-hydroxy acid)s series, which includes poly(lactic acid) (PLA) and poly(lactic-co-glycolic acid) (PLGA), is the most extensively researched class for drug delivery due to their degradation times of less than one year. PLA exists in several forms because the lactide monomer contains two chiral carbons: $D$-lactide, $L$-lactide (the cyclic dimer), mesolactide, and $DL$-lactide (racemic). While $PLLA$ is often used in long-term tissue engineering, Poly($DL$-lactide) is an amorphous, brittle polymer ideal for drug delivery. Adding glycolide to PLA lowers the $Tg$ and increases hydrophilicity. PLGA copolymers remain amorphous when the glycolide content is between $0.0\%$ and $70.0\%$. The fastest degradation, roughly two months, occurs in PLGA 50:50 (contains $50.0\%$ glycolide). The breakdown products, lactic acid and glycolic acid, are easily tolerated as they are part of the Krebs cycle.

Polyanhydrides were initially developed in the early 20th century by Carothers for textiles but became prominent in drug delivery due to their hydrolytic instability. Two major series exist today: the sebacic acid ($SA$) and carboxyphenoxypropane ($CPP$) series, and the fatty acid dimer and $SA$ series. A notable product is Gliadel, which uses P(CPP:SA 20:80) to release carmustine for brain tumor treatment. Polyanhydrides are unique because of their surface hydrophobicity, which prevents water absorption and leads to surface erosion. This erosion mechanism enables zero-order drug release, where the release rate is independent of the remaining drug concentration.

Polyphosphoesters are a newer class characterized by phosphate groups that act as internal plasticizers, making them flexible and solvent-soluble. Their hydrophilicity reduces protein adsorption and fouling. Polyphosphazenes feature an alternating phosphorus-nitrogen backbone. They are synthesized from poly(dichloro phosphazene) and organic nucleophiles. Water-soluble polyphosphazenes are particularly useful for sensitive biopharmaceuticals like vaccines and proteins because they can be processed entirely in aqueous solutions, often gelling in calcium chloride ($CaCl_2$) solutions.

Poly(orthoester)s (POEs) were specifically designed for controlled release in the 1970s. Modern variants like POE-IV include latent acid groups (lactic or glycolic acid) that autocatalyze degradation. Pseudopoly(amino acid)s are another class used in implants, replacing amide bonds in the backbone with non-amide bonds to improve processability. Tyrosine-derived polycarbonates, such as poly(DTE carbonate), have been investigated for intracranial dopamine release in Parkinson's disease treatment. Tyrosine-derived polyarylates represent a combinatorial library of $112$ individual polymers with incremental property gradients, designed for specific tailoring to applications.

ORAL AND PARENTERAL CONTROLLED RELEASE APPLICATIONS

In oral delivery, polymers facilitate drug release via diffusion, erosion, or a combination of both. Many systems use nonabsorbable biopolymers like cellulose or gums. In TIMERx technology, a blend of locust bean gum and xanthan gum forms noncovalent aggregates to control release. SODAS technology uses beads coated in layers of water-soluble and insoluble polymers. Targeted delivery to specific GI regions is a major focus; enteric coatings provide pH-dependent release, whereas colon targeting can be achieved using azopolymers or starch derivatives that are degraded by colonic enzymes. Gastric retention is another specialized application using superporous hydrogels. These are prepared by adding sodium bicarbonate during polymerization, generating carbon dioxide ($CO_2$) bubbles that create a porous structure. These hydrogels swell within $20$ minutes to a size larger than the pylorus, preventing removal from the stomach. Poly(vinyl pyrrolidone) is often explored for this purpose.

Parenteral delivery primarily utilizes PLA and PLGA, building on their established safety in medical sutures. Systems can involve microspheres, nanoparticles, or reversible gels. Sol-to-Gel polymers, such as PEG-PLGA block copolymers, transition from a liquid to a viscous gel as temperature rises, often around $37.0^{\circ}C$ for in vivo depot formation. Another method is solvent-induced gelation, where a polymer like PLGA is dissolved in an organic solvent (e.g., $N$-methyl pyrrolidone). When injected, the solvent diffuses away, leaving a solid polymer precipitate that traps the drug. This technology is used in Eligard for leuprolide acetate delivery.

For long-term delivery, nondegradable polymers offer several benefits: they do not cause pH changes (unlike acidic degradation products of PLA) and provide highly predictable release through diffusion or osmosis. Norplant is a key example, delivering levonorgestrel for up to $5$ years. Ocular implants like Ocusert provide sustained release of pilocarpine from an alginate complex sandwiched between ethylene-vinyl acetate membranes, delivering $20$ or $40.0\,mg/hr$ for up to seven days to manage glaucoma.

CRITICAL PARAMETERS IN POLYMER SELECTION

When selecting a polymer, regulatory approval status is a primary concern for rapid development. Physicochemical properties such as bulk hydrophilicity, morphology, and drug-polymer interactions are dictated by the polymer composition. Thermal attributes like the glass transition temperature ($Tg$) and melting temperature ($Tm$) are critical. Below the $Tg$, a polymer is in a glassy, amorphous state. Above the $Tg$, increased free volume and segmental chain mobility allow for faster mass transport. Processing often occurs above the $Tg$, while storage stability is better below it. Plasticizers (like residual solvents or the drug itself) lower the $Tg$, while chain rigidity and bulky side groups increase it. Furthermore, the presence of ionizable groups modulates polymer-drug interactions and solubility, thereby influencing the release rate.

MARKETED PRODUCTS UTILIZING POLYMERS (TABLE 12.21)

Several commercial products utilize PLA and PLGA for injectable sustained release. These include Decapeptyl (Triptorelin) and Trelstar Depot (Triptorelin pamoate) for prostate cancer by Debiopharm and Pfizer/LHRH respectively; Sandostatin LAR Depot (Octreotide acetate) for growth hormone suppression by Novartis; Eligard (Leuprolide acetate) for prostate cancer by Sanofi-Synthelabo; and Lupron Depot (Leuprolide acetate) for prostate cancer by Takeda-Abott. Other examples include Suprecur MP and Profect Depot (Buserelin acetate) by Aventis, Zoladex (Goserelin acetate) for prostate cancer by Astrazeneca, Posilac (Recombinant bovine somatropin) for cattle by Monsanto, Nutropin Depot (Recombinant human growth hormone) by Genentech-Alkermes, and Somatuline LA (Lanreotide) for acromegaly by Ipsen.

APPENDIX: COMPREHENSIVE LIST OF PHARMACEUTICAL EXCIPIENTS

Pharmaceutical excipients encompass a diverse range of chemical entities with varied functional roles. Aluminum hydroxide adjuvant/oxyhydroxide is accepted in human and veterinary vaccines with limits of $0.85\,mg$ Al per dose (FDA) or $1.25\,mg$ per dose (WHO). Ascorbic acid (L-ascorbic acid) and its derivative Ascorbyl palmitate serve as antioxidants. Aspartame (N-$\alpha$-Aspartyl-L-phenylalanine 1-methyl ester) is a potent sweetener. Bentonite (hydrated aluminum silicate) is used as an adsorbent and stabilizing agent. Benzalkonium chloride and Benzoic acid are common antimicrobial preservatives. Benzyl benzoate serves as a solvent and plasticizer, while Boric acid is another antimicrobial preservative.

Butylated hydroxyanisole ($BHA$) and Butylated hydroxytoluene ($BHT$) are widely used antioxidants in various dosage forms. Parabens, such as Butylparaben, Ethylparaben, and Propylparaben, provide antimicrobial protection. Calcium salts serve multiple roles: Calcium alginate is a thickener/disintegrant; Calcium carbonate acts as a diluent and buffering agent; and Calcium phosphate (dibasic anhydrous or dihydrate) is a common tablet filler. Calcium stearate and Magnesium stearate are primary lubricants for tablets and capsules. Polymers used as binders or modifiers include Carbomer (bioadhesive), Carboxymethylcellulose (sodium or calcium salts for disintegration), and Carrageenan (gel base). Different forms of Cellulose, including microcrystalline and powdered varieties, are ubiquitous diluents. Cellulose acetate and Cellulose acetate phthalate are used for enteric and extended-release coatings.

Surfactants and emulsifiers include Cetrimide (cationic), Cetyl alcohol, and Cetylpyridinium chloride. Chitosan is a natural polymer used for mucoadhesion. preservatives such as Chlorhexidine, Chlorobutanol, Chlorocresol, and Chloroxylenol are used in topicals and parenterals. Buffers and chelators like Citric acid monohydrate and Disodium edetate ($EDTA$) ensure formulation stability. Colloidal silicon dioxide ($SiO_2$) is an essential glidant. Disintegrants like Croscarmellose sodium and Crospovidone are used to ensure rapid tablet breakup. Cyclodextrins ($\alpha$, $\beta$, $\gamma$) and Sulfobutylether $\beta$-cyclodextrin are utilized to enhance drug solubility. Sweeteners include Dextrose, Fructose, Maltose, Mannitol, Saccharin, Sorbitol, Sucralose, and Sucrose, while Neohesperidin dihydrochalcone acts as a flavor enhancer. Solvent and vehicle examples include Dimethyl sulfoxide ($DMSO$), Ethyl lactate, Glycerin, Propylene glycol, and Isopropyl myristate/palmitate. Other notable agents include Gelatin (gelling), Guar gum (viscosity), Lanolin and Lecithin (emollients), and Titanium dioxide ($TiO_2$) as an opacifier. Zinc stearate and Talc serve as lubricants and glidants respectively.